| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on August 13, 2004
Accepted on November 8, 2004
Endocrinology Unit, School of Molecular and Clinical Medicine, University of Edinburgh, Molecular Medicine Centre, Western General Hospital, Edinburgh, United Kingdom EH4 2XU
* To whom correspondence should be addressed. E-mail: mandy.drake{at}ed.ac.uk.
Altered peripheral glucocorticoid metabolism may be important in the pathogenesis of obesity in humans and animal models. Genetically obese Zucker rats, lep/ob mice and obese humans exhibit increased regeneration of active glucocorticoids selectively in adipose tissue by 11
-hydroxysteroid dehydrogenase type 1 (11
-HSD-1) and increased glucocorticoid clearance by hepatic A-ring reductases. We have examined whether dietary obesity in rats induces the same changes in glucocorticoid metabolism.
Male Wistar rats were weaned onto high-fat (HF; 45% kcal from fat) or control (10% fat) diets. After 3 weeks, HF rats showed no differences in weight, but were glucose intolerant, had lower 11
-HSD-1 activity in liver (3.8 ± 0.2 vs. 4.9 ± 0.2 pmol product/min/mg protein, P < 0.01), subcutaneous (0.03 ± 0.01 vs. 0.09 ± 0.01 pmol product/min/mg protein, P < 0.01) and omental fat (0.02 ± 0.001 vs. 0.03 ± 0.003 pmol/ product/min/mg protein, P < 0.05), and higher hepatic 5
-reductase activity (0.26 ± 0.05 vs. 0.10 ± 0.007 pmol product/min/mg protein, P < 0.05). After 20 weeks, HF rats were obese, hyperglycaemic and hyperinsulinaemic but differences in 11
-HSD-1 and 5
-reductase activities were no longer apparent. Mature male rats given HF diets for 24 or 72 h showed increased hepatic 5
-reductase activity and a trend for decreased subcutaneous adipose 11
-HSD-1 activity.
Dietary obesity is not accompanied by the changes in 11
-HSD-1 and 5
-reductase expression and activity observed in genetically obese rodents. Acute exposure to high-fat diet alters glucocorticoid metabolism, predicting lower hepatic and adipose intracellular glucocorticoid concentrations which may be a key mechanism protecting against the metabolic complications of obesity.
-hydroxysteroid dehydrogenase
This article has been cited by other articles:
![]() |
S. Boullu-Ciocca, V. Achard, V. Tassistro, A. Dutour, and M. Grino Postnatal Programming of Glucocorticoid Metabolism in Rats Modulates High-Fat Diet-Induced Regulation of Visceral Adipose Tissue Glucocorticoid Exposure and Sensitivity and Adiponectin and Proinflammatory Adipokines Gene Expression in Adulthood Diabetes, March 1, 2008; 57(3): 669 - 677. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. H. Stimson, A. M. Johnstone, N. Z. M. Homer, D. J. Wake, N. M. Morton, R. Andrew, G. E. Lobley, and B. R. Walker Dietary Macronutrient Content Alters Cortisol Metabolism Independently of Body Weight Changes in Obese Men J. Clin. Endocrinol. Metab., November 1, 2007; 92(11): 4480 - 4484. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Qi and B. Rodrigues Glucocorticoids produce whole body insulin resistance with changes in cardiac metabolism Am J Physiol Endocrinol Metab, March 1, 2007; 292(3): E654 - E667. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |